D-0135-2018 Class III Terminated
FDA drug recall D-0135-2018 was initiated by Bayer HealthCare Pharmaceuticals, Inc. on Nov 10, 2017 and is designated Class III. Reason for recall: Failed Stability Specifications The recall status is terminated (terminated Apr 3, 2020). Affected quantity: 104,128 HDPE bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Jan 3, 2018
- Initiation Date
- Nov 10, 2017
- Termination Date
- Apr 3, 2020
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 104,128 HDPE bottles
Product description
Bayer Chewable Low Dose Aspirin 81 mg Orange Flavored 36 tablets, Made in Spain, Distributed by: Bayer Healthcare LLC Morristown, NJ 07962 NDC 0280-2160-36 UPC 3128431310577
Reason for recall
Failed Stability Specifications
Distribution pattern
Natonwide
Code information
Lot # NAA3T0X; Exp. 07/18
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0135-2018
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026